My name is Karrie Barrera-Larsen and I have an astrocytoma in the left front lobe/ wild type, but that is not who I am. I am a University of Michigan, Ann Arbor alumni who worked in the auto industry for over 2 decades. I worked on the first manuals created for the On Star system. I have created textile designs for the Jeep Wrangler seats that are still in use today. I helped to deploy a sophisticated engineering product lifecycle software application at Lear Corporation and later at IAC Automotive. While that was all happening I raised 5 kids. Our oldest is a recent grad from my alma mater and our youngest is going to be starting his last year of high school at Divine Child. I am married to my best friend and along with our 5 kids, and grand daughter, we also have 4 dogs. I have been battling my brain tumor since 2011 with a surgery, in 2012, radiation in 2015/16 and chemo treatments 2016/17. During that time I started working with Rodan + Fields as an independent consultant. I have since grown my business to include quite a large team and it continues to grow every month. Hopefully it’s the only thing that will keep growing, that I will be here to see my family keep growing, and that the tumor will remain stable….Each day, 500 people will be diagnosed with a brain tumor. To show my support, I will be participating in the American Brain Tumor Association’s BT5K Breakthrough for Brain Tumors Run & Walk. Money raised by the BT5K will provide critical funding for brain tumor research and for supportive patient care.
You can support me in my efforts by making a donation to the American Brain Tumor Association.
Click on “Donate Now” to donate safely and securely.
Your donation not only supports brain tumor patients and their families but it also supports the breakthrough research to improve, extend and ultimately save lives.
And remember, your donation is tax-deductible! You can learn more about the American Brain Tumor Association at www.abta.org. Thank you in advance for your support of my efforts on behalf of brain tumor patients, their families, and the researchers pursuing the breakthroughs.